Forskningsradar
← Alla bevakningsområden

Life Sciences

1736 artiklar · sida 29 av 70

🇸🇪 Endast svenska
5.1

Researchers found that acidity influences how two proteins bind together during cellular stress, a discovery with implications for understanding how cells survive harsh conditions. The finding could inform drug development targeting stress-related diseases, from cancer to neurodegeneration.EN

2023-01-01 · OPEN BIOLOGY · , , et al.
5.1

A Swedish study of hundreds of thousands of children found that antibiotic exposure during pregnancy and early childhood correlated with higher rates of autism and ADHD diagnoses. The finding has implications for pharmaceutical companies, pediatric care protocols, and parents—raising questions about when antibiotics are truly necessary in young children.EN

2023-01-01 · DRUG SAFETY · , , et al.
5.1

Researchers analyzing two decades of Swedish medical records found that pregnant women with acute hepatic porphyria face significantly elevated risks of severe complications and adverse outcomes. The findings could reshape clinical guidelines for managing this rare metabolic disorder in women of childbearing age, affecting treatment decisions and healthcare resource planning.EN

2023-01-01 · JOURNAL OF INHERITED METABOLIC DISEASE · , , et al.
5.1

Researchers tracked how neural damage indicators fluctuate in brain injury patients over time, using cerebrospinal fluid samples. The findings could help clinicians detect severity faster and monitor recovery, potentially improving treatment decisions and outcomes in a field where minutes matter.EN

2023-01-01 · NEUROTRAUMA REPORTS · , , et al.
5.1

Researchers have developed SkewC, a computational method to catch quality problems in single-cell RNA sequencing data early in the pipeline. The tool addresses a growing bottleneck in cell biology research: bad data wastes months of lab work and millions in research funding. For biotech firms and academic labs investing heavily in single-cell studies, early quality checks could slash costs and accelerate drug discovery timelines.EN

2023-01-01 · STAR PROTOCOLS · , , et al.
5.1

Researchers tested over 5,000 drugs and compounds to find alternatives for reactivating immune recognition of tumors, but failed completely. The finding confirms that cancer cells escaping immunotherapy largely do so by disabling a single critical pathway—suggesting no easy pharmaceutical shortcut exists for patients with resistant tumors.EN

2023-01-01 · MICROPUBLICATION BIOLOGY · , , et al.
5.1

Researchers have refined a method to observe mitochondrial DNA replication and gene expression in isolated cellular structures, offering a clearer window into how cells generate energy. The advance could accelerate drug development for mitochondrial diseases and help companies understand cellular dysfunction underlying metabolic disorders.EN

2023-01-01 · METHODS IN MOLECULAR BIOLOGY · ,
5.1

Researchers used advanced genetic sequencing to create the first comprehensive profile of mast cells in human lungs, revealing how these immune sentries respond to threats. The work could accelerate development of treatments for allergies, asthma, and other respiratory diseases that affect millions globally.EN

2023-01-01 · FRONTIERS IN IMMUNOLOGY · , , et al.
5.1

A large-scale analysis has found that maternal stress during pregnancy alters DNA methylation patterns in newborns—chemical modifications that can influence gene activity without changing DNA itself. The discovery could reshape how healthcare systems screen for early health risks and support pregnant women, with implications for preventive medicine and long-term health outcomes.EN

2023-01-01 · MOLECULAR PSYCHIATRY · , , et al.
5.1

Researchers discovered that children with Prader-Willi syndrome face elevated risk of pediatric cancers, particularly gonadal tumors, despite the condition not being classified as a cancer predisposition syndrome. The finding suggests a genetic mechanism involving imprinting relaxation and could reshape screening protocols and treatment strategies for the estimated 400,000 people worldwide living with the condition.EN

2023-01-01 · FRONTIERS IN MEDICINE · , , et al.
5.1

A new study reveals that healthcare workers in North-East Nigeria are unprepared to implement comprehensive cholera prevention strategies, jeopardizing outbreak response in a high-risk region. The findings point to critical gaps in training and knowledge that policy makers must address to prevent disease spread and protect public health infrastructure.EN

2023-01-01 · HUMAN RESOURCES FOR HEALTH · , , et al.
5.1

Swedish researchers identified thioredoxin reductase 1, a protein circulating in blood plasma, as a promising early warning sign for hepatocellular carcinoma. If validated in larger studies, the discovery could improve cancer screening and outcomes for at-risk patients, creating opportunities for diagnostic test developers and pharmaceutical companies.EN

2023-01-01 · SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY · , , et al.
5.1

Researchers identified sweeping epigenetic and genetic changes in T cells during pregnancy that correlate with MS symptom improvement, then reverse after birth. The findings could unlock new therapeutic targets for the neurological disease and inform how biologics companies approach immune-modulating treatments for autoimmune conditions.EN

2023-01-01 · JOURNAL OF NEUROINFLAMMATION · , , et al.
5.1

A highly resistant gonorrhea strain carrying a mutated resistance gene has jumped to a previously susceptible bacterial lineage and spread internationally, researchers reported. The discovery signals that a pathogen already difficult to treat is acquiring new genetic pathways to evade antibiotics, complicating treatment options for a common sexually transmitted infection.EN

2023-01-01 · EUROSURVEILLANCE · , , et al.
5.1

Researchers found that acyl ghrelin, a naturally occurring hormone, restores heart function in heart failure patients by improving how effectively heart muscle contracts—using an entirely different mechanism than existing drugs. The discovery could lead to new treatments for the millions worldwide living with heart failure, a condition that costs healthcare systems billions annually.EN

2023-01-01 · EUROPEAN HEART JOURNAL · , , et al.
5.1

A comprehensive overview of genotyping methods helps laboratories and biotech firms navigate competing technologies for DNA analysis. The review clarifies trade-offs between speed, cost, and accuracy—critical for companies developing diagnostics, precision medicine tools, and agricultural genomics applications.EN

2023-01-01 · CURRENT PROTOCOLS · , ,
5.1

A large Swedish registry analysis found that transcranial magnetic stimulation—a non-invasive brain treatment—effectively treats depression in patients who haven't responded to medication. The finding could reshape how health systems manage treatment-resistant depression, reducing reliance on pharmaceutical interventions and potentially lowering long-term care costs.EN

2023-01-01 · JOURNAL OF AFFECTIVE DISORDERS · , , et al.
5.1

Researchers found that changes in how Parkinson's patients read correlate with worse overall cognitive function, suggesting reading difficulties may serve as an early warning sign. This discovery could help clinicians identify cognitive decline faster and improve care planning for neurodegeneration patients.EN

2023-01-01 · MOVEMENT DISORDERS CLINICAL PRACTICE · , , et al.
5.1

Radiologists have developed a systematic approach to diagnosing skeletal dysplasias—rare inherited bone disorders affecting children and adults. The stepwise framework could reduce diagnostic delays that currently leave patients without treatment options, while cutting unnecessary testing costs for healthcare systems managing these complex cases.EN

2023-01-01 · RADIOGRAPHICS · , ,
5.1

A chromosomal variation affecting roughly 1 in 1,000 people shows measurable impacts on brain development in children, according to new research from Swedish twins tracked into adulthood. The findings could help clinicians identify at-risk children earlier and inform genetic counseling for families, while opening new markets for diagnostic testing and targeted interventions.EN

2023-01-01 · MOLECULAR GENETICS & GENOMIC MEDICINE · , , et al.
5.1

Researchers found that a specific form of a common protein helps stabilize dangerous arterial plaques and reduces heart attack risk. The discovery could lead to new treatments targeting heart disease, the leading cause of death globally, and may reshape how doctors assess which patients face the greatest cardiovascular danger.EN

2023-01-01 · CARDIOVASCULAR RESEARCH · , , et al.
5.1

Researchers found that abnormal function in a specific inner ear canal can signal poor recovery prospects for patients with sudden severe hearing loss. The finding could help clinicians identify which patients need aggressive early intervention, potentially improving treatment decisions and patient outcomes in a condition that currently affects thousands annually.EN

2023-01-01 · FRONTIERS IN NEUROLOGY · , , et al.
5.1

Researchers in Southeast China have developed a risk assessment tool that blends genetic markers with lifestyle factors to predict breast cancer susceptibility. The approach could help insurers, healthcare systems, and pharmaceutical companies better stratify patients and personalize prevention strategies in an underserved population.EN

2023-01-01 · CANCER MEDICINE · , , et al.
5.1

Researchers tested whether over-the-counter ibuprofen interferes with muscle building during resistance training and found it has minimal impact on the biological mechanisms that drive hypertrophy. The finding matters for fitness enthusiasts and supplement makers: it suggests casual painkiller use won't sabotage workout gains, though questions remain about higher doses or chronic use.EN

2023-01-01 · JOURNAL OF APPLIED PHYSIOLOGY · , , et al.
5.1

Researchers have identified how a protein linked to Alzheimer's disease binds to metabolic enzymes in the cell, potentially opening new drug targets. The discovery could help pharmaceutical companies develop therapies that intercept disease mechanisms earlier, before significant neurological damage occurs.EN

2023-01-01 · JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS · , , et al.